WHAT WE'RE FOCUSED ON
CELL THERAPY DEVELOPMENT PIPELINE
OTHER AREAS OF INTEREST
As our company grows, we will be extending our research programs in orthopedic as well as cardiovascular conditions. There are so many conditions that our stem cells could benefit and we rely on the public to help us determine the priorities.
Conservatively, it takes about half a billion dollars to bring a drug to market. This enormous burden explains why drug costs are so high and why emerging therapies have such a hard time making it to market. Our development costs are limited due to the fact that our cell product is the same for various indications. We are still required to take each indication into phased clinical trials. However, through creative research partnerships and generous support from various funding sources, we have a successful model for continued development. The majority of our stem cell banking, products and services revenue are used to fund our research. Our end goal is to get our product to patients as soon as possible at the lowest possible cost. If you are interested in helping this endeavor and would like to support one of our many research projects, or would like to propose your own, please contact us.